Sentence examples for models preclinical studies from inspiring English sources

Ojima says, "Once we have drug candidates that are ready to go into animal models, preclinical studies, toxicology, and such things, it really takes companies to do that".

Before these strategies can be applied to humans, animal models, preclinical studies and appropriately designed human clinical trials are needed to test different treatments and provide information on their safety and efficacy.

Although human biology is only partially predictable from experimental animal models, preclinical studies remain an important element in the scientific development of stem cell-based therapy, which provide fundamental basis for clinical practice.

Using these models, preclinical studies using several individual angiogenic factors, including VEGFs, FGFs, HIF-1α and HGF, have showed significant improvements in clinically relevant end points such as increased regional perfusion, improved exercise tolerance and tissue energy metabolism, improved myocardial function, and protection against ischemic damage.

Ideally, a randomized controlled trial format in preclinical research would essentially adapt established concepts from clinical trials and model preclinical studies according to this format, and include all core concepts of sound clinical trial design (Begg et al., 1996) (FDA Clinical Trials Guidance Documents, http://www.fda.gov/RegulatoryInformation/Guidances/ucm122046.htm, May 30 , 2012.

Despite the advantages of using xenograft models in preclinical studies, there are also many limitations to these models that must be addressed.

We would like to stress that, depending on the scientific questions, the CAM model may well be used instead of mouse models in preclinical studies.

Ultimately, the use of these models in preclinical studies provides a vital framework from which to continue to evaluate therapies and identify predictive and prognostic markers in vivo.

Following the recommendations of Varticovski et al. [ 19] about the limitations of using genetically engineered mouse models in preclinical studies, we generated a transplanted orthotopic and syngeneic model from the original transgenic mice.

The importance of animal models for preclinical studies is indisputable, and many researchers have proposed several animal models in the last several decades, which include canine, rabbit, and rodent models, but none of them have been able to reliably reproduce a sustained chronic effect similar to that found in human secondary (postsurgical) lymphedema [ 3].

In support of the need for refined models, recent preclinical studies clearly demonstrated that whilst anti-angiogenic therapies can be effective at controlling tumour growth in models of the primary disease, the same therapies were not effective in models of the adjuvant or metastatic treatment setting [ 202, 246].